BESIVANCE

This brand name is authorized in Brazil, Canada, Singapore, Turkey, United States

Active ingredients

The drug BESIVANCE contains one active pharmaceutical ingredient (API):

1 Besifloxacin UNII BFE2NBZ7NX - BESIFLOXACIN

Besifloxacin is a fluoroquinolone antibacterial indicated for the treatment of bacterial conjunctivitis. Read about Besifloxacin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BESIVANCE Ophthalmic suspension	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01AE08		S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AE Fluoroquinolones
Discover more medicines within S01AE08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 503101301134315
Country: CA	Health Products and Food Branch	Identifier(s): 02336847
Country: SG	Health Sciences Authority	Identifier(s): 14021P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699856712278
Country: US	FDA, National Drug Code	Identifier(s): 24208-446